HVT Share Price | Delivra Health Brands, Inc. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

18.72 k

Shareholding (Sep 2020)

FII

0.02%

Held by 1 FIIs

DII

99.98%

Held by 0 DIIs

Promoter

0.00%

Compare Delivra Health Brands, Inc. with Similar Stocks

Christina Lake Cannabis Corp.Slang Worldwide, Inc.Refined Energy Corp.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

The company has declared negative results for the last 2 consecutive quarters

The company has declared negative results in Dec 25 after 2 consecutive negative quarters
ROCE(HY) Lowest at -28.27%
DEBT-EQUITY RATIO (HY) Highest at -10.37 %
RAW MATERIAL COST(Y) Grown by 38% (YoY)

Risky -

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Other Agricultural Products

Market cap

CAD 3 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.10

Return on Equity

-37.46%

Price to Book

1.06

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Mar 2026)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-28.57%

6 Months

-57.45%

1 Year

-50.0%

2 Years

-71.43%

3 Years

566.67%

4 Years

185.71%

5 Years

17.65%

Delivra Health Brands, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

4.11%

EBIT Growth (5y)

14.06%

EBIT to Interest (avg)

-5.40

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.30

Sales to Capital Employed (avg)

2.00

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.02%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.06

EV to EBIT

-2.82

EV to EBITDA

-2.82

EV to Capital Employed

1.07

EV to Sales

0.25

PEG Ratio

Dividend Yield

ROCE (Latest)

-36.33%

ROE (Latest)

-37.46%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

No Trend

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2020

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.02%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -50.00% vs -25.00% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -150.00% vs -300.00% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.20",
          "val2": "2.40",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.00",
          "val2": "-0.40",
          "chgp": "-150.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.00",
          "val2": "-0.40",
          "chgp": "-150.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-784.30%",
          "val2": "-185.00%",
          "chgp": "-59.93%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2025 is 8.06% vs 26.53% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2025 is -233.33% vs 550.00% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "13.40",
          "val2": "12.40",
          "chgp": "8.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.40",
          "val2": "0.60",
          "chgp": "-33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "1.90",
          "chgp": "-105.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.20",
          "val2": "0.90",
          "chgp": "-233.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-62.90%",
          "val2": "-57.40%",
          "chgp": "-0.55%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

1.20

2.40

-50.00%

Operating Profit (PBDIT) excl Other Income

-1.00

-0.40

-150.00%

Interest

0.10

Exceptional Items

0.00

0.10

-100.00%

Consolidate Net Profit

-1.00

-0.40

-150.00%

Operating Profit Margin (Excl OI)

-784.30%

-185.00%

-59.93%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -50.00% vs -25.00% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -150.00% vs -300.00% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Jun'25

Jun'25

Jun'24

Change(%)

Net Sales

13.40

12.40

8.06%

Operating Profit (PBDIT) excl Other Income

0.40

0.60

-33.33%

Interest

0.10

0.20

-50.00%

Exceptional Items

-0.10

1.90

-105.26%

Consolidate Net Profit

-1.20

0.90

-233.33%

Operating Profit Margin (Excl OI)

-62.90%

-57.40%

-0.55%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Jun 2025 is 8.06% vs 26.53% in Jun 2024

Consolidated Net Profit

YoY Growth in year ended Jun 2025 is -233.33% vs 550.00% in Jun 2024

All Annual Results

Company CV

About Delivra Health Brands, Inc.

Delivra Health Brands, Inc.

Other Agricultural Products

Harvest One Cannabis Inc.(Harvest One) is a Canada-based company that develops and distributes health, wellness and selfcare products with a market focus on sleep, pain, and anxiety. The Company's subsidiaries include Satipharm Limited (Satipharm), Dream Water Global, and Delivra Corp. (Delivra). Satipharm is a health & wellbeing company, which is specialized in the development and manufacture of cannabinoid-based products from the cannabis plant. Dream Water Global is engaged in selling natural, 0-calorie, liquid sleep shot. Delivra manufactures and sells a line of natural topical creams with the transdermal delivery system platform under the LivRelief brand, for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance.

Company Coordinates

Company Details

Suite 404, 999 Canada Place , VANCOUVER BC : V6C 3E2

Tel: 1 604 4499280

https://www.harvestone.com

Registrar Details